Journal home
Advance online publication
Current issue
Archive
Press releases
Supplements
Focuses
Guide to authors
Online submissionOnline submission
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
Reprints and permissions
About this site
For librarians
 
NPG Resources
Nature
Nature Reviews
Nature Immunology
Nature Cell Biology
Nature Genetics
news@nature.com
Nature Conferences
Dissect Medicine
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
Article
Nature Medicine  10, 966 - 973 (2004)
Published online: 22 August 2004; | doi:10.1038/nm1099

The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm

Lei Zhao1, Michael P W Moos2, Rolf Gräbner2, Frédérique Pédrono1, 3, Jinjin Fan1, Brigitte Kaiser2, Nicole John2, Sandra Schmidt2, Rainer Spanbroek2, Katharina Lötzer2, Li Huang4, Jisong Cui4, Daniel J Rader1, 5, Jilly F Evans4, Andreas J R Habenicht2 & Colin D Funk1, 3, 5, 6

1  Center for Experimental Therapeutics, University of Pennsylvania, Philadelphia, Pennsylvania 19104-6160, USA.

2  Institute for Vascular Medicine, Friedrich-Schiller University of Jena, Bachstrasse 18, 07743 Jena, Germany.

3  Departments of Physiology and Biochemistry, Queen's University, Kingston, Ontario K7L 3N6, Canada.

4  Department of Cardiovascular Diseases, Merck & Company, Rahway, New Jersey 07065, USA.

5  Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104-6160, USA.

6  Department of Pharmacology, University of Pennsylvania, Philadelphia, Pennsylvania 19104-6160, USA.

Correspondence should be addressed to Colin D Funk funkc@post.queensu.ca
Activation of the 5-lipoxygenase (5-LO) pathway leads to the biosynthesis of proinflammatory leukotriene lipid mediators. Genetic studies have associated 5-LO and its accessory protein, 5-LO-activating protein, with cardiovascular disease, myocardial infarction and stroke. Here we show that 5-LO-positive macrophages localize to the adventitia of diseased mouse and human arteries in areas of neoangiogenesis and that these cells constitute a main component of aortic aneurysms induced by an atherogenic diet containing cholate in mice deficient in apolipoprotein E. 5-LO deficiency markedly attenuates the formation of these aneurysms and is associated with reduced matrix metalloproteinase-2 activity and diminished plasma macrophage inflammatory protein-1alpha (MIP-1alpha; also called CCL3), but only minimally affects the formation of lipid-rich lesions. The leukotriene LTD4 strongly stimulates expression of MIP-1alpha in macrophages and MIP-2 (also called CXCL2) in endothelial cells. These data link the 5-LO pathway to hyperlipidemia-dependent inflammation of the arterial wall and to pathogenesis of aortic aneurysms through a potential chemokine intermediary route.

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

Aneurysms: leukotrienes weaken aorta from the outside

Nature Medicine News and Views (01 Sep 2004)

 Top
Abstract
Previous | Next
Table of contents
Full textFull text
Download PDFDownload PDF
Send to a friendSend to a friend

Open Innovation Challenges

Figures & Tables
Supplementary info
See also: News and Views by Palinski
Export citation
natureproducts

Search buyers guide:

 
ADVERTISEMENT
 
Nature Medicine
ISSN: 1078-8956
EISSN: 1546-170X
Journal home | Advance online publication | Current issue | Archive | Press releases | Supplements | Focuses | For authors | Online submission | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | Reprints and permissions | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©2004 Nature Publishing Group | Privacy policy